US SEC Filing Intelligence

DHS Homeland Security Contracts — March 08, 2026

GardaWorld Federal Services LLC secured a $313.4M DHS/ICE delivery order for renovating and operating a detention facility in Surprise, AZ, with ceiling potential of $704.1M via options, signaling robust demand for private infrastructure in immigration enforcement. This firm fixed-price award to the BC Partners-backed firm highlights sector tailwinds amid rising detention needs. Key risks include cost overruns and execution delays, but option exercises could drive 2.2x revenue upside by 2029.

VA Healthcare & Services Contracts — March 08, 2026

A single massive $1.28B VA EHRM contract awarded to Oracle Health Government Services provides substantial long-term revenue visibility through May 2026, signaling bullish momentum for Oracle's government health IT segment. However, zero funds outlayed to date despite the obligation raises execution risk, warranting caution amid firm-fixed-price exposure to inflation. Investors should monitor funding releases and options exercise for near-term catalysts.

HHS & Healthcare Contracts Intelligence — March 08, 2026

Amgen USA Inc. secured a $774M HHS/BARDA contract for 10-year biotech R&D on thrombocytopenia treatments for mass casualty events, with $712M already outlayed, providing stable long-term federal revenue amid high execution. This sole award highlights concentrated BARDA support for biodefense biotech, positioning Amgen favorably but exposing it to cost overrun risks under firm fixed price terms. Investors should monitor option exercises worth $143M and potential follow-ons post-2032.

Federal IT & Cybersecurity Contracts — March 08, 2026

Oracle Health Government Services secured a $1.28B VA contract for EHRM hosting and management through mid-2026, signaling strong long-term revenue visibility in federal health IT amid zero competition. However, zero funds outlayed despite massive obligation flags potential execution delays or funding constraints. This single large award underscores concentration risk in VA IT spending but highlights sector stability via extended firm-fixed-price commitments.

New Federal Contractors — March 08, 2026

New federal contracts disclose $6.17B in obligations (potential $14.2B incl. options) across 6 awards, all bullish for non-small govcon firms in DOE remediation (71% of value), defense R&D, health IT/biotech, and DHS facilities. Savannah River Mission Completion dominates with $2.37B DOE awards for 8-year Savannah River site work (potential $8.42B), signaling prioritized nuclear cleanup spend through 2031. Long-dated terms to 2032 and $5B+ in options offer multi-year revenue tailwinds amid high outlays ($2.66B already spent).

Significant Contract Modifications ($10M+) — March 08, 2026

Six significant contract modifications totaling $6.17B obligated value signal strong federal commitment to long-term missions, led by $2.37B DOE awards to Savannah River Mission Completion LLC for Savannah River site remediation through 2031. Unobligated options exceed $5B across contracts, offering substantial upside for contractors in remediation, defense R&D, health IT, and biotech. All awards to non-small businesses via full/open competition highlight stability for large-cap providers amid execution risks from firm-fixed pricing and low near-term outlays.

Contract Deobligations Alert — March 08, 2026

Six bullish contract signals totaling $6.2B in obligations highlight stable long-term federal revenue for key contractors, with DOE's Savannah River remediation dominating at ~$2.4B obligated (up to $8.4B potential) across two awards to the same LLC. Unobligated options exceed $5B across the portfolio, signaling upside in defense R&D, health IT, biotech, and security services. Long performance periods (avg. 8+ years) provide revenue visibility through 2032 amid full/open competition wins by non-small businesses.

Contract Option Exercises — March 08, 2026

Six bullish contract exercises totaling $6.2B in obligations signal robust federal spending on long-term missions, with DOE's Savannah River Mission Completion LLC capturing $2.4B (39% of total) for nuclear remediation through 2031. Significant upside lies in $10B+ unobligated options across defense R&D, health IT, biotech, and detention facilities. Institutional investors should prioritize contractors with multi-year visibility amid steady outlays ($2.7B already spent).

All HHS Contracts — March 08, 2026

HHS awarded Amgen a $774M (potential $917M) 10-year BARDA contract for biotech R&D targeting thrombocytopenia in mass casualty events, with $712M already outlayed signaling strong federal commitment to biodefense. This provides Amgen stable long-term revenue amid full competition win as a large biotech player. Investors should monitor front-loaded spending risks and $143M unobligated options for upside.

All DOE Contracts — March 08, 2026

DOE awarded two task orders totaling $2.37B obligated ($8.42B potential with options) to Savannah River Mission Completion, LLC under the single Integrated Mission Completion Contract for Savannah River site remediation through 2031. This concentration signals robust, long-term federal commitment to nuclear liquid waste and tank closure operations (NAICS 562910). Key upside lies in ~$6.1B unobligated options, providing multi-year revenue visibility amid stable remediation needs.

2 total filings

Mega Contracts Monitor ($100M+) — March 08, 2026

Six mega contracts totaling $6.2B obligated value signal strong federal commitment to long-term projects in DOE remediation, defense R&D, health IT, biotech, and DHS facilities, with Savannah River Mission Completion capturing 40% ($2.37B) via two DOE awards. All bullish with $14B+ potential via options, providing multi-year revenue visibility through 2032 amid steady outlays in mature contracts. Investors should prioritize DOE environmental services and health/gov IT for stable cash flows, monitoring option exercises for 2x+ upside.

High-Value Federal Grants ($5M+) — March 08, 2026

Six high-value federal contracts totaling $6.2B obligated (up to $14.2B with options) signal robust demand for remediation, defense IT, health tech, biotech R&D, and immigration facilities, with all bullish outlooks and long-term visibility to 2032. DOE dominates via two awards to Savannah River Mission Completion LLC ($2.37B obligated, $8.4B potential), representing 38% of obligated value and highlighting nuclear cleanup priority. Investors gain multi-year revenue tailwinds but must monitor option exercises and execution amid firm-fixed-price exposures.

DOE Energy Grants — March 08, 2026

DOE awarded Savannah River Mission Completion, LLC two delivery orders totaling $2.37B obligated (potential $8.42B including options) under the Integrated Mission Completion Contract for sequential Task Orders 6 (liquid waste, $7.39B pot.) and 7 (tank closure, $1.03B pot.) at Savannah River site through 2031. This concentration signals strong federal commitment to remediation, securing ~$1.97B outlays to date and $6.06B unobligated upside for the non-small U.S.-owned LLC. Bullish for contractor revenue stability amid DOE's long-term nuclear waste priorities.

2 total filings

General Federal Contracts — March 08, 2026

Federal contracts totaling $6.17B in obligations highlight DOE's dominant $2.37B commitment to Savannah River Mission Completion LLC for long-term nuclear remediation, representing 38% of volume with $8.4B option ceiling. Bullish signals across defense R&D, health IT, biotech, and security underscore stable revenue through 2032, with $10B+ in unobligated options for upside. No bearish indicators, but long durations and firm-fixed structures flag execution risks amid high outlays in some ($2.7B total).

1 high priority 1 total filings

Global High-Priority Regulatory Events — March 08, 2026

The single filing in the Global High Priority Market Events stream features Ashok Leyland Limited's clarification under SEBI Regulation 30(11), deeming a March 6, 2026, Economic Times article and Chennai press conference non-material, with share price movements attributed solely to general market conditions. Neutral sentiment and low materiality (3/10) indicate no substantive impact or new catalysts, reinforcing the company's disclosure discipline without introducing volatility drivers. No period-over-period comparisons (YoY/QoQ revenue, margins) or financial ratios are present in the enriched data, suggesting stable underlying operations absent red flags. Absent insider trading activity, forward-looking guidance, capital allocation updates (dividends/buybacks), or transaction details further underscore this as a non-event. Key implication: reduces rumor-driven trading risks for ASHOKLEY (NSE)/500477 (BSE) investors. Portfolio-level pattern from 1/1 filings: emerging market firms proactively clarifying rumors to maintain transparency amid high-priority event scrutiny. Actionable takeaway: maintain positions, as no enriched data signals shifts in growth trends, management conviction, or scheduled events.

DOE Energy & National Labs Contracts — March 07, 2026

DOE's NNSA awarded General Atomics a non-competitive $91.4M contract for inertial confinement fusion (ICF) targets R&D, part of a $547M ceiling through potential 2035, signaling robust revenue visibility and established dominance in high-priority national lab work. Cost-plus-fixed-fee structure lowers execution risk amid $43.6M already outlayed. Investors gain bullish exposure to sustained U.S. fusion energy R&D funding, with $456M in unobligated options as key upside.

DHS Homeland Security Contracts — March 07, 2026

DHS CBP awarded $6.15B in 10 firm fixed price contracts for Texas border barriers/walls, signaling massive infrastructure spend starting March 2026 with $0 outlays to date except one legacy deal. Barnard Construction dominates with 42% ($2.59B across 3 awards), followed by Spencer (15%, $954M across 3) and Fisher Sand (20%, $1.22B), offering high-confidence revenue visibility through 2028. All open-competition wins highlight sector resurgence, but execution risks loom from cost-plus exposure and remote TX sites.

10 total filings

VA Healthcare & Services Contracts — March 07, 2026

Optum Public Sector Solutions (UnitedHealth Group subsidiary) captured 100% of $1.14B in VA medical-managed healthcare delivery orders awarded in this period, underscoring UNH's dominance in government healthcare services (PSC Q201). Both 1-month contracts (Nov/Dec 2025 performance) carry bullish revenue potential but face execution hurdles from $0 outlayed and post-performance award dates. Concentration risk is high as all value flows to one entity in the health insurance sector (NAICS 524114).

2 total filings